Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Endosc. Aug 16, 2021; 13(8): 319-328
Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.319
Figure 1
Figure 1 Esophagectomy approaches for patients with esophagogastric junction adenocarcinoma. A: Final mediastinal aspect after esophagectomy with lymphadenectomy by thoracoscopic transthoracic esophagectomy technique for patients with esophagogastric junction adenocarcinoma (a: Thoracic aorta; b: Left pulmonary vein; c: Right pulmonary vein; d: Left bronchi’s; e: Right bronchus; and f: Azygous vein); B: Final mediastinal aspect after esophagectomy with lymphadenectomy by transhiatal esophagectomy technique for patients with esophagogastric junction adenocarcinoma (a: Left hepatic lobe; b: Caudate hepatic lobe; c: Right diaphragmatic pilar; d: Left diaphragmatic pilar; e: Thoracic aorta; and f: Distal esophagus).
Figure 2
Figure 2 Overall survival of patients with adenocarcinoma of the esophagogastric junction who underwent esophagectomy. A: Early (P = 0.002); B: Advanced cases (P = 0.32).